Eyepoint Pharmaceuticals (EYPT) USD0.01
Sell:$17.72Buy:$17.75
$0.79 (4.63%)
- This stock can be held in a
Stocks and Shares ISASell:$17.72
Buy:$17.75
Change:$0.79 (4.63%)
$0.79 (4.63%)Prices delayed by at least 15 minutes
Sell:$17.72
Buy:$17.75
Change:$0.79 (4.63%)
$0.79 (4.63%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 18 April 2024 | CORMORANT ASSET MANAGEMENT LPAsset Management Company | Buy Regular purchase transaction | 186,521 | $18.90 | $3,525,246.90 | 7,475,000 |
| 18 April 2024 | CORMORANT ASSET MANAGEMENT LPAsset Management Company | Buy Regular purchase transaction | 395,244 | $17.62 | $6,964,199.28 | 7,288,479 |
| 30 March 2024 | Dario A PaggiarinoOther Level A | Sell Tax related | 15,493 | $20.67 | $320,240.31 | 77,133 |
| 30 March 2024 | Dario A PaggiarinoOther Level A | Sell Tax related | 2,957 | $20.67 | $61,121.19 | 74,176 |
| 30 March 2024 | Dario A PaggiarinoOther Level A | Sell Tax related | 7,096 | $20.67 | $146,674.32 | 67,080 |
| 9 February 2024 | Nancy S. LurkerOther Chairman | Sell Tax related | 7,962 | $28.80 | $229,305.60 | 165,013 |
| 9 February 2024 | Nancy S. LurkerOther Chairman | Sell Tax related | 6,981 | $28.80 | $201,052.80 | 158,032 |
| 9 February 2024 | Jay S DukerPresident/COO | Sell Tax related | 2,075 | $28.80 | $59,760.00 | 53,378 |
| 9 February 2024 | Jay S DukerPresident/COO | Sell Tax related | 1,458 | $28.80 | $41,990.40 | 51,920 |
| 9 February 2024 | David Scott JonesChief Level Officer | Sell Tax related | 1,955 | $28.80 | $56,304.00 | 46,617 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 11 January 2024 | OCUMENSION THERAPEUTICSOther Legal Entity | Sell Regular sell transaction (market) | 1,910,500 | $19.45 | $37,159,225.00 | 100,221 |
| 4 December 2023 | CORMORANT ASSET MANAGEMENT LPAsset Management Company | Buy Regular purchase transaction | 945,664 | $19.88 | $18,799,800.32 | 4,797,866 |
| 11 January 2024 | CORMORANT ASSET MANAGEMENT LPAsset Management Company | Buy Regular purchase transaction | 750,000 | $19.75 | $14,812,500.00 | 6,893,235 |
| 5 December 2023 | OCUMENSION THERAPEUTICSOther Legal Entity | Sell Regular sell transaction (market) | 733,758 | $19.91 | $14,609,121.78 | 2,276,963 |
| 8 December 2023 | CORMORANT ASSET MANAGEMENT LPAsset Management Company | Buy Regular purchase transaction | 588,235 | $17.00 | $9,999,995.00 | 6,038,235 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.